<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2023-1-4-17</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-1947</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>Predictive capabilities of the Cloninger Temperament and Character Inventory (TCI) in evaluating the effectiveness of antidepressant pharmacotherapy. Systematic review and meta-analysis</article-title><trans-title-group xml:lang="ru"><trans-title>Прогностические возможности Опросника темперамента и характера Клонингера (TCI) при оценке эффективности антидепрессивной фармакотерапии. Систематический обзор и метаанализ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9605-8527</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Овчинников</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ovchinnikov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алексей Валерьевич Овчинников</p><p>119034, Москва, Кропоткинский пер., 23</p></bio><bio xml:lang="en"><p>119034, Moscow, Kropotkinsky Per., 23</p></bio><email xlink:type="simple">ovchinnikov.alexy@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6018-402X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вазагаева</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vazagaeva</surname><given-names>T. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119034, Москва, Кропоткинский пер., 23</p></bio><bio xml:lang="en"><p>119034, Moscow, Kropotkinsky Per., 23</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7045-0547</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ахапкин</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Akhapkin</surname><given-names>R. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119034, Москва, Кропоткинский пер., 23</p></bio><bio xml:lang="en"><p>119034, Moscow, Kropotkinsky Per., 23</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1667-5355</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волель</surname><given-names>Б. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Volel</surname><given-names>B. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119021, Москва, ул. Россолимо, 11, стр. 2</p></bio><bio xml:lang="en"><p>119021, Moscow, Rossolimo St., 11, Build. 2</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр психиатрии и наркологии им. В.П. Сербского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Psychiatry and Narcology named after V.P. Serbsky, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>16</day><month>02</month><year>2023</year></pub-date><volume>15</volume><issue>1</issue><fpage>4</fpage><lpage>17</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ovchinnikov A.V., Vazagaeva T.I., Akhapkin R.V., Volel B.A., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Овчинников А.В., Вазагаева Т.И., Ахапкин Р.В., Волель Б.А.</copyright-holder><copyright-holder xml:lang="en">Ovchinnikov A.V., Vazagaeva T.I., Akhapkin R.V., Volel B.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/1947">https://nnp.ima-press.net/nnp/article/view/1947</self-uri><abstract><p>In the pharmacotherapy of depressive disorders, the problem of the predictors of a therapeutic response remains relevant, they may be important in determining treatment tactics.Objective: to determine the predictive power of the Cloninger Temperament and Character Inventory (TCI) in evaluating the results of antidepressant pharmacotherapy in patients with depression (major depressive disorder).Material and methods. PubMed and Google Scholar were searched for articles published between 1990 and November 2021. Only English-language prospective studies, that examined the relationship between pre-treatment TCI personality scores and antidepressant pharmacotherapy efficacy were selected.Results. A total of 18 studies were found (Ntot=3122). The most commonly cited statistically significant predictors of therapy effectiveness were: harm avoidance (HA) in 11 studies (Ntot=2413), reward dependence in 6 (Ntot=1941), cooperativeness (CO) in 6 (Ntot=1259). In only two studies (Ntot=234), personality parameters were not associated with treatment efficacy. In 10 studies (Ntot=1065) baseline values of personality characteristics were indicated, which made it possible to include them in the meta-analysis. HA (z=4.06; p&lt;0.0001; I2 =49%) and CO (z=2.71; p=0.007; I2 =66%) were associated – in a statistically significant way – with the likelihood of achieving a response to antidepressant pharmacotherapy.Conclusion. Personality dimensions from the TCI questionnaire are predictors of the effectiveness of antidepressant pharmacotherapy</p></abstract><trans-abstract xml:lang="ru"><p>В фармакотерапии депрессивных расстройств остается актуальной проблема поиска предикторов терапевтического ответа, учет которых может иметь важное значение в определении тактики лечения.Целю настоящего обзора является определение прогностических возможностей Опросника темперамента и характера Клонингера (Temperament and Character Inventory, TCI) в оценке результатов антидепрессивной фармакотерапии у пациентов с депрессией (большим депрессивным расстройством).Материал и методы. Поиск литературы проводился в системах PubMed и Google Scholar среди статей, опубликованных в период с 1990 г. по ноябрь 2021 г. Отбирались только англоязычные проспективные исследования, в которых изучалась связь между значениями личностных характеристик из опросника TCI, полученными до начала лечения, и эффективностью антидепрессивной фармакотерапии.Результаты. Всего удалось найти 18 исследований (Nсум=3122). В качестве статистически значимых предикторов эффективности терапии чаще всего назывались: избегание опасности (ИО) – в 11 исследованиях (Nсум=2413), зависимость от вознаграждения – в 6 (Nсум=1941), сотрудничество (СО) – в 6 (Nсум=1259). Всего в двух исследованиях (Nсум= 234) параметры личности не были связаны с эффективностью терапии. В 10 исследованиях (Nсум=1065) указывались фоновые значения личностных характеристик, что позволило включить их в метаанализ. ИО (z=4,06; p&lt;0,0001; I2=49%) и СО (z=2,71; p=0,007; I2=66%) были статистически значимо связаны с вероятностью достижения ответа на антидепрессивную фармакотерапию.Заключение. Личностные дименсии из опросника TCI являются предикторами эффективности антидепрессивной фармакотерапии.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>депрессия</kwd><kwd>терапия</kwd><kwd>предикторы</kwd><kwd>личность</kwd><kwd>TCI</kwd></kwd-group><kwd-group xml:lang="en"><kwd>depression</kwd><kwd>therapy</kwd><kwd>predictors</kwd><kwd>personality</kwd><kwd>TCI</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905-17. doi:10.1176/ajp.2006.163.11.1905</mixed-citation><mixed-citation xml:lang="en">Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905-17. doi:10.1176/ajp.2006.163.11.1905</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986 Autumn;4(3):167-226.</mixed-citation><mixed-citation xml:lang="en">Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986 Autumn;4(3):167-226.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993 Dec;50(12):975-90. doi:10.1001/archpsyc.1993.01820240059008</mixed-citation><mixed-citation xml:lang="en">Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993 Dec;50(12):975-90. doi:10.1001/archpsyc.1993.01820240059008</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Service SK, Verweij KJ, Lahti J, et al. A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales. Transl Psychiatry. 2012 May 15;2(5):e116. doi:10.1038/tp.2012.37</mixed-citation><mixed-citation xml:lang="en">Service SK, Verweij KJ, Lahti J, et al. A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales. Transl Psychiatry. 2012 May 15;2(5):e116. doi:10.1038/tp.2012.37</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry. 2002 Mar;159(3):359-71. doi:10.1176/appi.ajp.159.3.359</mixed-citation><mixed-citation xml:lang="en">Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry. 2002 Mar;159(3):359-71. doi:10.1176/appi.ajp.159.3.359</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kampman O, Poutanen O. Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. J Affect Disord. 2011 Dec;135(1-3):20-7. doi:10.1016/j.jad.2010.12.021. Epub 2011 Jan 22.</mixed-citation><mixed-citation xml:lang="en">Kampman O, Poutanen O. Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. J Affect Disord. 2011 Dec;135(1-3):20-7. doi:10.1016/j.jad.2010.12.021. Epub 2011 Jan 22.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Jul 21;339:b2700. doi:10.1136/bmj.b2700</mixed-citation><mixed-citation xml:lang="en">Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Jul 21;339:b2700. doi:10.1136/bmj.b2700</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Study Quality Assessment Tools. U.S. Department of Health &amp; Human Services Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed 20.11.2021).</mixed-citation><mixed-citation xml:lang="en">Study Quality Assessment Tools. U.S. Department of Health &amp; Human Services Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed 20.11.2021).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Corruble E, Duret C, Pelissolo A, et al. Early and delayed personality changes associated with depression recovery? A one-year follow-up study. Psychiatry Res. 2002 Jan 31;109(1):17-25. doi:10.1016/s0165-1781(01)00366-3</mixed-citation><mixed-citation xml:lang="en">Corruble E, Duret C, Pelissolo A, et al. Early and delayed personality changes associated with depression recovery? A one-year follow-up study. Psychiatry Res. 2002 Jan 31;109(1):17-25. doi:10.1016/s0165-1781(01)00366-3</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chien AJ, Dunner DL. The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiatr Res. 1996 Jan-Feb;30(1):21-7. doi:10.1016/0022-3956(95)00041-0</mixed-citation><mixed-citation xml:lang="en">Chien AJ, Dunner DL. The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiatr Res. 1996 Jan-Feb;30(1):21-7. doi:10.1016/0022-3956(95)00041-0</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Takahashi M, Suzuki M, Muneoka K, et al. Personality traits as predictors for the outcome of lithium augmentation in treatment-resistant depression. Psychiatry Res. 2014 Dec 30;220(3):1144-6. doi:10.1016/j.psychres.2014.09.023</mixed-citation><mixed-citation xml:lang="en">Takahashi M, Suzuki M, Muneoka K, et al. Personality traits as predictors for the outcome of lithium augmentation in treatment-resistant depression. Psychiatry Res. 2014 Dec 30;220(3):1144-6. doi:10.1016/j.psychres.2014.09.023</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Joffe RT, Bagby RM, Levitt AJ, et al. The Tridimensional Personality Questionnaire in major depression. Am J Psychiatry. 1993;150:959-60. doi:10.1176/ajp.150.6.959</mixed-citation><mixed-citation xml:lang="en">Joffe RT, Bagby RM, Levitt AJ, et al. The Tridimensional Personality Questionnaire in major depression. Am J Psychiatry. 1993;150:959-60. doi:10.1176/ajp.150.6.959</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Joyce PR, Mulder RT, Cloninger CR. Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord. 1994 Jan;30(1):35-46. doi:10.1016/0165-0327(94)90149-x</mixed-citation><mixed-citation xml:lang="en">Joyce PR, Mulder RT, Cloninger CR. Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord. 1994 Jan;30(1):35-46. doi:10.1016/0165-0327(94)90149-x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson E, Cloninger CR. Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study. J Affect Disord. 1997 Jul;44(2-3):197-200. doi:10.1016/s0165-0327(97)00047-5</mixed-citation><mixed-citation xml:lang="en">Nelson E, Cloninger CR. Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study. J Affect Disord. 1997 Jul;44(2-3):197-200. doi:10.1016/s0165-0327(97)00047-5</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tome MB, Cloninger CR, Watson JP, Isaac MT. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. J Affect Disord. 1997 Jul;44(2-3):101-9. doi:10.1016/s0165-0327(97)00030-x</mixed-citation><mixed-citation xml:lang="en">Tome MB, Cloninger CR, Watson JP, Isaac MT. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. J Affect Disord. 1997 Jul;44(2-3):101-9. doi:10.1016/s0165-0327(97)00030-x</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sato T, Hirano S, Narita T, et al. Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression. J Affect Disord. 1999 Dec;56(2-3):153-61. doi:10.1016/s0165-0327(99)00047-6</mixed-citation><mixed-citation xml:lang="en">Sato T, Hirano S, Narita T, et al. Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression. J Affect Disord. 1999 Dec;56(2-3):153-61. doi:10.1016/s0165-0327(99)00047-6</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Newman JR, Ewing SE, McColl RD, et al. Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study. J Affect Disord. 2000 Jan-Mar;57(1-3):241-7. doi:10.1016/s0165-0327(99)00046-4</mixed-citation><mixed-citation xml:lang="en">Newman JR, Ewing SE, McColl RD, et al. Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study. J Affect Disord. 2000 Jan-Mar;57(1-3):241-7. doi:10.1016/s0165-0327(99)00046-4</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Marijnissen G, Tuinier S, Sijben AE, Verhoeven WM. The temperament and character inventory in major depression. J Affect Disord. 2002 Jul;70(2):219-23. doi:10.1016/s0165-0327(01)00364-0</mixed-citation><mixed-citation xml:lang="en">Marijnissen G, Tuinier S, Sijben AE, Verhoeven WM. The temperament and character inventory in major depression. J Affect Disord. 2002 Jul;70(2):219-23. doi:10.1016/s0165-0327(01)00364-0</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Abrams KY, Yune SK, Kim SJ, et al. Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder. Psychiatry Clin Neurosci. 2004 Jun;58(3):240-8. doi:10.1111/j.1440-1819.2004.01226.x</mixed-citation><mixed-citation xml:lang="en">Abrams KY, Yune SK, Kim SJ, et al. Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder. Psychiatry Clin Neurosci. 2004 Jun;58(3):240-8. doi:10.1111/j.1440-1819.2004.01226.x</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mulder RT, Joyce PR, Frampton CM, et al. Six months of treatment for depression: outcome and predictors of the course of illness. Am J Psychiatry. 2006 Jan;163(1):95-100. doi:10.1176/appi.ajp.163.1.95</mixed-citation><mixed-citation xml:lang="en">Mulder RT, Joyce PR, Frampton CM, et al. Six months of treatment for depression: outcome and predictors of the course of illness. Am J Psychiatry. 2006 Jan;163(1):95-100. doi:10.1176/appi.ajp.163.1.95</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kaneda A, Yasui-Furukori N, Nakagami T, et al. The influence of personality factors on paroxetine response time in patients with major depression. J Affect Disord. 2011 Dec;135(1-3):321-5. doi:10.1016/j.jad.2011.06.050. Epub 2011 Jul 23.</mixed-citation><mixed-citation xml:lang="en">Kaneda A, Yasui-Furukori N, Nakagami T, et al. The influence of personality factors on paroxetine response time in patients with major depression. J Affect Disord. 2011 Dec;135(1-3):321-5. doi:10.1016/j.jad.2011.06.050. Epub 2011 Jul 23.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kronström K, Salminen JK, Hietala J, et al. Personality traits and recovery from major depressive disorder. Nord J Psychiatry. 2011 Feb;65(1):52-7. doi:10.3109/08039488.2010.487571. Epub 2010 May 26.</mixed-citation><mixed-citation xml:lang="en">Kronström K, Salminen JK, Hietala J, et al. Personality traits and recovery from major depressive disorder. Nord J Psychiatry. 2011 Feb;65(1):52-7. doi:10.3109/08039488.2010.487571. Epub 2010 May 26.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kampman O, Poutanen O, Illi A, et al. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients. Eur Psychiatry. 2012 May;27(4):245-9. doi:10.1016/j.eurpsy.2010.07.006. Epub 2010 Oct 8.</mixed-citation><mixed-citation xml:lang="en">Kampman O, Poutanen O, Illi A, et al. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients. Eur Psychiatry. 2012 May;27(4):245-9. doi:10.1016/j.eurpsy.2010.07.006. Epub 2010 Oct 8.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Nishioka G, Yashima H, Kiuchi Y, et al. Prediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorder. Hum Psychopharmacol. 2013 Nov;28(6):576-85. doi:10.1002/hup.2347. Epub 2013 Oct 7.</mixed-citation><mixed-citation xml:lang="en">Nishioka G, Yashima H, Kiuchi Y, et al. Prediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorder. Hum Psychopharmacol. 2013 Nov;28(6):576-85. doi:10.1002/hup.2347. Epub 2013 Oct 7.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Tomita T, Ishioka M, Kaneda A, et al. An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder. J Affect Disord. 2014 Aug;165:109-13. doi:10.1016/j.jad.2014.04.076. Epub 2014 May 4.</mixed-citation><mixed-citation xml:lang="en">Tomita T, Ishioka M, Kaneda A, et al. An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder. J Affect Disord. 2014 Aug;165:109-13. doi:10.1016/j.jad.2014.04.076. Epub 2014 May 4.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Balestri M, Porcelli S, Souery D, et al. Temperament and character influence on depression treatment outcome. J Affect Disord. 2019 Jun 1;252:464-74. doi:10.1016/j.jad.2019.04.031. Epub 2019 Apr 9.</mixed-citation><mixed-citation xml:lang="en">Balestri M, Porcelli S, Souery D, et al. Temperament and character influence on depression treatment outcome. J Affect Disord. 2019 Jun 1;252:464-74. doi:10.1016/j.jad.2019.04.031. Epub 2019 Apr 9.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Gurpegui D, Ortuno F, Gurpegui M. Temperament traits and remission of depression: A naturalistic six-month longitudinal study. J Affect Disord. 2019 Jan 15;243:494-502. doi:10.1016/j.jad.2018.09.041. Epub 2018 Sep 17.</mixed-citation><mixed-citation xml:lang="en">Gurpegui D, Ortuno F, Gurpegui M. Temperament traits and remission of depression: A naturalistic six-month longitudinal study. J Affect Disord. 2019 Jan 15;243:494-502. doi:10.1016/j.jad.2018.09.041. Epub 2018 Sep 17.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Köhler-Forsberg O, Keers R, Uher R, et al. Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram. Psychol Med. 2021 Nov 12:1-9. doi:10.1017/S003329172100444X. Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Köhler-Forsberg O, Keers R, Uher R, et al. Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram. Psychol Med. 2021 Nov 12:1-9. doi:10.1017/S003329172100444X. Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Cloninger CR, Svrakic DM, Przybeck TR. Can personality assessment predict future depression? A twelve-month follow-up of 631 subjects. J Affect Disord. 2006 May;92(1):35-44. doi:10.1016/j.jad.2005.12.034. Epub 2006 Jan 26.</mixed-citation><mixed-citation xml:lang="en">Cloninger CR, Svrakic DM, Przybeck TR. Can personality assessment predict future depression? A twelve-month follow-up of 631 subjects. J Affect Disord. 2006 May;92(1):35-44. doi:10.1016/j.jad.2005.12.034. Epub 2006 Jan 26.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ahola A, Rautio N, Timonen M, et al. Premorbid temperament as predictor of onset of depression: 23-year follow-up. Compr Psychiatry. 2022 Dec 5;121:152359. doi:10.1016/j.comppsych.2022.152359. Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Ahola A, Rautio N, Timonen M, et al. Premorbid temperament as predictor of onset of depression: 23-year follow-up. Compr Psychiatry. 2022 Dec 5;121:152359. doi:10.1016/j.comppsych.2022.152359. Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Farmer A, Mahmood A, Redman K, et al. A sib-pair study of the Temperament and Character Inventory scales in major depression. Arch Gen Psychiatry. 2003 May;60(5):490-6. doi:10.1001/archpsyc.60.5.490</mixed-citation><mixed-citation xml:lang="en">Farmer A, Mahmood A, Redman K, et al. A sib-pair study of the Temperament and Character Inventory scales in major depression. Arch Gen Psychiatry. 2003 May;60(5):490-6. doi:10.1001/archpsyc.60.5.490</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Xia J, He Q, Li Y, et al. The relationship between neuroticism, major depressive disorder and comorbid disorders in Chinese women. J Affect Disord. 2011;135(1-3):100-5. doi:10.1016/j.jad.2011.06.053</mixed-citation><mixed-citation xml:lang="en">Xia J, He Q, Li Y, et al. The relationship between neuroticism, major depressive disorder and comorbid disorders in Chinese women. J Affect Disord. 2011;135(1-3):100-5. doi:10.1016/j.jad.2011.06.053</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Noteboom A, Beekman ATF, Vogelzangs N, Penninx BWJH. Personality and social support as predictors of first and recurrent episodes of depression. J Affect Disord. 2016 Jan 15;190:156-61. doi:10.1016/j.jad.2015.09.020. Epub 2015 Oct 23.</mixed-citation><mixed-citation xml:lang="en">Noteboom A, Beekman ATF, Vogelzangs N, Penninx BWJH. Personality and social support as predictors of first and recurrent episodes of depression. J Affect Disord. 2016 Jan 15;190:156-61. doi:10.1016/j.jad.2015.09.020. Epub 2015 Oct 23.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Vinkers CH, Joёls M, Milaneschi Y, et al. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depress Anxiety. 2014 Sep;31(9):737-45. doi:10.1002/da.22262. Epub 2014 Apr 17.</mixed-citation><mixed-citation xml:lang="en">Vinkers CH, Joёls M, Milaneschi Y, et al. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depress Anxiety. 2014 Sep;31(9):737-45. doi:10.1002/da.22262. Epub 2014 Apr 17.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Гаранян НГ. Депрессия и личность: обзор зарубежных исследований. Часть 1. Социальная и клиническая психиатрия. 2009;19(1):79-89.</mixed-citation><mixed-citation xml:lang="en">Garanyan NG. Depression and personality: review of foreign investigations: Part 1. Social’naya i klinicheskaya psixiatriya. 2009;19(1):79-89 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Calvet B, Pericaud M, Parneix M, et al. Age and sex differences in temperament and character dimensions in a French nonclinical population. J Individ Dif. 2016;37(3):168-80. doi:10.1027/1614-0001/a000203</mixed-citation><mixed-citation xml:lang="en">Calvet B, Pericaud M, Parneix M, et al. Age and sex differences in temperament and character dimensions in a French nonclinical population. J Individ Dif. 2016;37(3):168-80. doi:10.1027/1614-0001/a000203</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Quilty LC, Godfrey KM, Kennedy SH, Bagby RM. Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychother Psychosom. 2010;79(2):116-22. doi:10.1159/000276372. Epub 2010 Jan 20.</mixed-citation><mixed-citation xml:lang="en">Quilty LC, Godfrey KM, Kennedy SH, Bagby RM. Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychother Psychosom. 2010;79(2):116-22. doi:10.1159/000276372. Epub 2010 Jan 20.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five Factor Inventory (NEO-FFI) Professional Manual. Odessa: Psychological Assessment Resources; 1992.</mixed-citation><mixed-citation xml:lang="en">Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five Factor Inventory (NEO-FFI) Professional Manual. Odessa: Psychological Assessment Resources; 1992.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">De Fruyt F, Van De Wiele L, Heeringen CV. Cloninger’s psychobiological model of temperament and character and the five-factor model of personality. Pers Individ Dif. 2000;29:441-52.</mixed-citation><mixed-citation xml:lang="en">De Fruyt F, Van De Wiele L, Heeringen CV. Cloninger’s psychobiological model of temperament and character and the five-factor model of personality. Pers Individ Dif. 2000;29:441-52.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Quilty LC, Meusel LA, Bagby RM. Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder. J Affect Disord. 2008 Nov;111(1):67-73. doi:10.1016/j.jad.2008.02.006. Epub 2008 Apr 2.</mixed-citation><mixed-citation xml:lang="en">Quilty LC, Meusel LA, Bagby RM. Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder. J Affect Disord. 2008 Nov;111(1):67-73. doi:10.1016/j.jad.2008.02.006. Epub 2008 Apr 2.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bagby RM, Psych C, Quilty LC, Ryder AC. Personality and depression. Can J Psychiatry. 2008 Jan;53(1):14-25. doi:10.1177/070674370805300104</mixed-citation><mixed-citation xml:lang="en">Bagby RM, Psych C, Quilty LC, Ryder AC. Personality and depression. Can J Psychiatry. 2008 Jan;53(1):14-25. doi:10.1177/070674370805300104</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
